{"id":"https://openalex.org/W2005995062","doi":"https://doi.org/10.2147/odrr.s43409","title":"Post-marketing access to orphan drugs: a critical analysis of health technology assessment and reimbursement decision-making considerations","display_name":"Post-marketing access to orphan drugs: a critical analysis of health technology assessment and reimbursement decision-making considerations","publication_year":2014,"publication_date":"2014-01-01","ids":{"openalex":"https://openalex.org/W2005995062","doi":"https://doi.org/10.2147/odrr.s43409","mag":"2005995062"},"language":"en","primary_location":{"id":"doi:10.2147/odrr.s43409","doi":"https://doi.org/10.2147/odrr.s43409","is_oa":true,"landing_page_url":"https://doi.org/10.2147/odrr.s43409","pdf_url":"https://www.dovepress.com/getfile.php?fileID=18650","source":{"id":"https://openalex.org/S4210195907","display_name":"Orphan Drugs Research and Reviews","issn_l":"2230-6161","issn":["2230-6161"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-20"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Orphan Drugs: Research and Reviews","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://www.dovepress.com/getfile.php?fileID=18650","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5078668305","display_name":"Georgi G. Iskrov","orcid":"https://orcid.org/0000-0002-0988-0062","observed_orcids":["https://orcid.org/0000-0002-0988-0062"]},"institutions":[{"id":"https://openalex.org/I2801117330","display_name":"Medical University Plovdiv","ror":"https://ror.org/02kzxd152","country_code":"BG","type":"education","lineage":["https://openalex.org/I2801117330"]}],"countries":["BG"],"is_corresponding":true,"raw_author_name":"Georgi Iskrov","raw_affiliation_strings":["Department of Social Medicine and Public Health , Faculty of Public Health , Medical University of Plovdiv 15 A , vasil Aprilov Blvd , 4002 Plovdiv , Bulgaria","Department of Social Medicine and Public Health, Medical University of Plovdiv, Plovdiv, Bulgaria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Social Medicine and Public Health , Faculty of Public Health , Medical University of Plovdiv 15 A , vasil Aprilov Blvd , 4002 Plovdiv , Bulgaria","institution_ids":["https://openalex.org/I2801117330"]},{"raw_affiliation_string":"Department of Social Medicine and Public Health, Medical University of Plovdiv, Plovdiv, Bulgaria","institution_ids":["https://openalex.org/I2801117330"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5080192946","display_name":"Rumen S. Stefanov","orcid":"https://orcid.org/0000-0003-3587-7278","observed_orcids":["https://orcid.org/0000-0003-3587-7278"]},"institutions":[{"id":"https://openalex.org/I2801117330","display_name":"Medical University Plovdiv","ror":"https://ror.org/02kzxd152","country_code":"BG","type":"education","lineage":["https://openalex.org/I2801117330"]}],"countries":["BG"],"is_corresponding":true,"raw_author_name":"Rumen Stefanov","raw_affiliation_strings":["Department of Social Medicine and Public Health, Medical University of Plovdiv, Plovdiv, Bulgaria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Social Medicine and Public Health, Medical University of Plovdiv, Plovdiv, Bulgaria","institution_ids":["https://openalex.org/I2801117330"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5078668305","https://openalex.org/A5080192946"],"corresponding_institution_ids":["https://openalex.org/I2801117330"],"apc_list":null,"apc_paid":null,"fwci":11.154,"has_fulltext":true,"cited_by_count":37,"citation_normalized_percentile":{"value":0.97940024,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":99},"biblio":{"volume":null,"issue":null,"first_page":"1","last_page":"1"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.5820000171661377,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.5820000171661377,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.41190001368522644,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/orphan-drugs","display_name":"orphan drugs","score":1.0},{"id":"https://openalex.org/keywords/health-technology-assessment","display_name":"health technology assessment","score":0.984000027179718},{"id":"https://openalex.org/keywords/reimbursement-decision-making","display_name":"reimbursement decision-making","score":0.7940000295639038},{"id":"https://openalex.org/keywords/rare-diseases","display_name":"rare diseases","score":0.6650000214576721},{"id":"https://openalex.org/keywords/cost-effectiveness-threshold","display_name":"cost-effectiveness threshold","score":0.8309999704360962},{"id":"https://openalex.org/keywords/budget-impact","display_name":"budget impact","score":0.9179999828338623},{"id":"https://openalex.org/keywords/uncertainty-in-evidence","display_name":"evidence uncertainty","score":0.7260000109672546},{"id":"https://openalex.org/keywords/economic-evaluation","display_name":"economic evaluation","score":0.5979999899864197}],"concepts":[{"id":"https://openalex.org/C75480439","wikidata":"https://www.wikidata.org/wiki/Q1367466","display_name":"Orphan drug","level":2,"score":0.8256566524505615},{"id":"https://openalex.org/C2779703844","wikidata":"https://www.wikidata.org/wiki/Q760125","display_name":"Reimbursement","level":3,"score":0.7914214730262756},{"id":"https://openalex.org/C21333345","wikidata":"https://www.wikidata.org/wiki/Q1519843","display_name":"Health technology","level":3,"score":0.64568692445755},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.513985812664032},{"id":"https://openalex.org/C162853370","wikidata":"https://www.wikidata.org/wiki/Q39809","display_name":"Marketing","level":1,"score":0.4021846055984497},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.18445342779159546},{"id":"https://openalex.org/C160735492","wikidata":"https://www.wikidata.org/wiki/Q31207","display_name":"Health care","level":2,"score":0.17433682084083557},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.10366758704185486},{"id":"https://openalex.org/C50522688","wikidata":"https://www.wikidata.org/wiki/Q189833","display_name":"Economic growth","level":1,"score":0.07698515057563782},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.2147/odrr.s43409","doi":"https://doi.org/10.2147/odrr.s43409","is_oa":true,"landing_page_url":"https://doi.org/10.2147/odrr.s43409","pdf_url":"https://www.dovepress.com/getfile.php?fileID=18650","source":{"id":"https://openalex.org/S4210195907","display_name":"Orphan Drugs Research and Reviews","issn_l":"2230-6161","issn":["2230-6161"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-20"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Orphan Drugs: Research and Reviews","raw_type":"journal-article"},{"id":"pmh:oai:dovepress.com/15466","doi":null,"is_oa":true,"landing_page_url":"https://www.dovepress.com/post-marketing-access-to-orphan-drugs-a-critical-analysis-of-health-te-peer-reviewed-article-ODRR","pdf_url":null,"source":{"id":"https://openalex.org/S4306401012","display_name":"Dove Medical Press (Taylor and Francis Group)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Review"}],"best_oa_location":{"id":"doi:10.2147/odrr.s43409","doi":"https://doi.org/10.2147/odrr.s43409","is_oa":true,"landing_page_url":"https://doi.org/10.2147/odrr.s43409","pdf_url":"https://www.dovepress.com/getfile.php?fileID=18650","source":{"id":"https://openalex.org/S4210195907","display_name":"Orphan Drugs Research and Reviews","issn_l":"2230-6161","issn":["2230-6161"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-20"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Orphan Drugs: Research and Reviews","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.6240000128746033}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2005995062.pdf","grobid_xml":"https://content.openalex.org/works/W2005995062.grobid-xml"},"referenced_works_count":24,"referenced_works":["https://openalex.org/W1579507411","https://openalex.org/W1966909822","https://openalex.org/W1995517770","https://openalex.org/W1997389468","https://openalex.org/W2010913334","https://openalex.org/W2055755669","https://openalex.org/W2073559015","https://openalex.org/W2084906650","https://openalex.org/W2092086165","https://openalex.org/W2105479110","https://openalex.org/W2107886799","https://openalex.org/W2113987058","https://openalex.org/W2117810230","https://openalex.org/W2120240121","https://openalex.org/W2124811712","https://openalex.org/W2125250410","https://openalex.org/W2126502186","https://openalex.org/W2143685252","https://openalex.org/W2160488963","https://openalex.org/W2161078130","https://openalex.org/W2165663095","https://openalex.org/W2169826871","https://openalex.org/W4241348467","https://openalex.org/W6827775559"],"related_works":["https://openalex.org/W1979518377","https://openalex.org/W2997997888","https://openalex.org/W2333729558","https://openalex.org/W2905951388","https://openalex.org/W2526574420","https://openalex.org/W2085325623","https://openalex.org/W2404325326","https://openalex.org/W7222963827","https://openalex.org/W4319333517","https://openalex.org/W2900298321"],"abstract_inverted_index":{"Abstract:":[0],"This":[1],"study":[2],"aims":[3],"to":[4,12,17,74,83,94,99,107,163,183,191,234],"explore":[5],"the":[6,55,87,100,178,209,217,231,269],"current":[7],"rationale":[8],"of":[9,58,89,91,123,151,171,177,196,211,239,262,274],"post-marketing":[10],"access":[11,16,233],"orphan":[13,18,43,92,104,140,146,197,212,257,263,287],"drugs.":[14,44],"As":[15],"medicinal":[19],"products":[20],"depends":[21],"on":[22,33,168],"assessment":[23,36,283],"and":[24,38,80,106,112,129,136,157,247,251,260,281,284],"appraisal":[25],"by":[26],"health":[27,34,154,289],"authorities,":[28],"this":[29,63,224],"article":[30],"is":[31,77,148,200,215,226],"focused":[32],"technology":[35,290],"(HTA)":[37],"reimbursement":[39,101,127],"decision-making":[40,102,144,293],"considerations":[41],"for":[42,115,145,180,185,220,230,271,279],"A":[45],"critical":[46],"analysis":[47,167],"may":[48],"identify":[49],"important":[50,96],"factors":[51],"that":[52,208],"could":[53,267],"predetermine":[54],"combined":[56],"outcomes":[57],"these":[59,202,235],"two":[60],"processes.":[61],"Following":[62],"objective,":[64],"an":[65,139,174],"analytical":[66],"framework":[67],"was":[68],"developed,":[69],"comprising":[70],"three":[71],"overlaying":[72],"issues:":[73],"outline":[75],"what":[76,81],"currently":[78],"done":[79,85],"needs":[82],"be":[84],"in":[86,126],"field":[88],"HTA":[90,130],"drugs,":[93,105,288],"synthesize":[95],"variables":[97],"relevant":[98],"about":[103],"unveil":[108],"relationships":[109],"between":[110],"theory":[111],"practice.":[113],"Methods":[114],"economic":[116],"evaluation,":[117],"cost-effectiveness":[118],"threshold,":[119],"budget":[120],"impact,":[121],"uncertainty":[122],"evidence,":[124,275],"criteria":[125],"decision-making,":[128],"research":[131],"agenda":[132],"are":[133,203],"all":[134],"explored":[135],"discussed":[137],"from":[138],"drug":[141,198,213,258],"perspective.":[142],"Reimbursement":[143],"drugs":[147],"a":[149,165,169,193],"debate":[150],"policy":[152],"priorities,":[153],"system":[155],"specifics,":[156],"societal":[158],"attitudes.":[159],"Health":[160],"authorities":[161],"need":[162],"pursue":[164],"multidisciplinary":[166],"range":[170],"criteria,":[172],"ensuring":[173],"explicit":[175],"understanding":[176],"trade-offs":[179],"decisions":[181],"related":[182],"eligibility":[184],"reimbursement.":[186],"The":[187,237],"only":[188],"reasonable":[189],"way":[190],"accept":[192],"higher":[194],"valuation":[195],"benefits":[199],"if":[201],"demonstrated":[204],"empirically.":[205],"Rarity":[206],"means":[207],"quality":[210],"evidence":[214,240],"not":[216],"same":[218],"as":[219,276,278],"conventional":[221],"therapies.":[222],"Closing":[223],"gap":[225],"another":[227],"crucial":[228],"point":[229],"timely":[232,282],"products.":[236],"generation":[238],"goes":[241],"far":[242],"beyond":[243],"pre-market":[244],"authorization":[245],"trials":[246],"requires":[248],"transnational":[249],"cooperation":[250],"coordination.":[252],"Early":[253],"constructive":[254],"dialogue":[255],"among":[256],"stakeholders":[259],"elaboration":[261],"drug-tailored":[264],"methodology":[265],"tools":[266],"set":[268],"scene":[270],"ongoing":[272],"accumulation":[273],"well":[277],"proper":[280],"appraisal.":[285],"Keywords:":[286],"assessment,":[291],"reimbursement,":[292]},"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":8},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":7},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}